Priority Aviat Stock Price, News & Analysis
Company Description
Priority Aviat (OTC Link: PJET) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $9.8K.
This page provides a comprehensive overview of PJET stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Priority Aviat (PJET) stock last traded at $0.0000. At a market capitalization of $9.8K, PJET is classified as a micro-cap stock with approximately 980.1M shares outstanding.
Latest News
Priority Aviat has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, partnership. View all PJET news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Priority Aviat (PJET) currently stands at 233.8 thousand shares. With 14.8 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Priority Aviat (PJET) currently stands at 14.8 days, up 689.3% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 91.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.3 to 584.5 days.
PJET Company Profile & Sector Positioning
Priority Aviat (PJET) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing PJET often look at related companies in the same sector, including Item 9 Labs (INLB), Mjardin Group (MJARF), Industry Source Consulting Inc (INSO), Avivagen (VIVXF), and Wowi (WOWU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate PJET's relative position within its industry.